Louise Chen

Stock Analyst at Cantor Fitzgerald

(3.82)
# 700
Out of 4,650 analysts
281
Total ratings
57.56%
Success rate
5.78%
Average return

Stocks Rated by Louise Chen

Pfizer
Oct 25, 2024
Reiterates: Overweight
Price Target: $45
Current: $28.86
Upside: +55.93%
Zai Lab
Oct 25, 2024
Reiterates: Overweight
Price Target: n/a
Current: $32.54
Upside: -
Johnson & Johnson
Oct 16, 2024
Reiterates: Overweight
Price Target: $215
Current: $161.60
Upside: +33.04%
Zevra Therapeutics
Oct 11, 2024
Reiterates: Overweight
Price Target: n/a
Current: $8.05
Upside: -
Novo Nordisk
Oct 10, 2024
Reiterates: Overweight
Price Target: $160
Current: $112.36
Upside: +42.40%
Merck & Co.
Oct 3, 2024
Reiterates: Overweight
Price Target: $155
Current: $104.23
Upside: +48.71%
Roivant Sciences
Sep 19, 2024
Reiterates: Overweight
Price Target: n/a
Current: $11.84
Upside: -
Eli Lilly
Sep 16, 2024
Reiterates: Overweight
Price Target: $885
Current: $895.59
Upside: -1.18%
Evolus
Sep 16, 2024
Reiterates: Overweight
Price Target: n/a
Current: $16.27
Upside: -
Immunovant
Sep 9, 2024
Reiterates: Overweight
Price Target: n/a
Current: $29.95
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $9.11
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $0.25
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $12.47
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $1.29
Upside: -
Reiterates: Overweight
Price Target: $200
Current: $189.68
Upside: +5.44%
Reiterates: Overweight
Price Target: n/a
Current: $19.93
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $112.80
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $1.45
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $5.90
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $2.06
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $0.63
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $3.30
Upside: -
Reiterates: Neutral
Price Target: $925
Current: $928.61
Upside: -0.39%
Reiterates: Overweight
Price Target: n/a
Current: $1.42
Upside: -
Reiterates: Overweight
Price Target: $65
Current: $17.49
Upside: +271.64%
Downgrades: Neutral
Price Target: n/a
Current: $1.61
Upside: -
Reiterates: Overweight
Price Target: $5
Current: $1.26
Upside: +296.83%
Reiterates: Overweight
Price Target: $25
Current: $1.19
Upside: +2,000.84%
Reiterates: Overweight
Price Target: $50
Current: $20.65
Upside: +142.13%
Reiterates: Overweight
Price Target: $50
Current: $8.71
Upside: +474.05%
Reiterates: Neutral
Price Target: $5
Current: $1.57
Upside: +219.49%
Maintains: Overweight
Price Target: $5$9
Current: $2.84
Upside: +216.90%
Maintains: Neutral
Price Target: $33$21
Current: $0.67
Upside: +3,043.71%
Initiates: Overweight
Price Target: $67,500
Current: $1.13
Upside: +5,973,351.33%
Maintains: Neutral
Price Target: $240$258
Current: $459.29
Upside: -43.83%
Maintains: Neutral
Price Target: $9$15
Current: $18.37
Upside: -18.35%
Maintains: Overweight
Price Target: $40$50
Current: $1.91
Upside: +2,517.80%
Initiates: Overweight
Price Target: $20
Current: $1.50
Upside: +1,233.33%
Initiates: Overweight
Price Target: $50
Current: $5.90
Upside: +747.46%
Initiates: Overweight
Price Target: $45
Current: $6.00
Upside: +650.00%